Rempart Asset Management Inc. Sells 2,990 Shares of Colgate-Palmolive (NYSE:CL)

Rempart Asset Management Inc. reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 251,618 shares of the company’s stock after selling 2,990 shares during the quarter. Colgate-Palmolive comprises 4.6% of Rempart Asset Management Inc.’s portfolio, making the stock its 8th biggest position. Rempart Asset Management Inc.’s holdings in Colgate-Palmolive were worth $22,875,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Northcape Capital Pty Ltd increased its holdings in shares of Colgate-Palmolive by 4.9% in the fourth quarter. Northcape Capital Pty Ltd now owns 6,012 shares of the company’s stock worth $547,000 after acquiring an additional 282 shares in the last quarter. Range Financial Group LLC lifted its stake in Colgate-Palmolive by 117.8% in the 4th quarter. Range Financial Group LLC now owns 10,436 shares of the company’s stock valued at $949,000 after purchasing an additional 5,644 shares during the last quarter. Bath Savings Trust Co increased its position in Colgate-Palmolive by 2.9% during the fourth quarter. Bath Savings Trust Co now owns 58,137 shares of the company’s stock worth $5,285,000 after buying an additional 1,655 shares during the last quarter. Diversified Trust Co raised its stake in Colgate-Palmolive by 2.6% in the 4th quarter. Diversified Trust Co now owns 83,360 shares of the company’s stock valued at $7,578,000 after acquiring an additional 2,125 shares during the period. Finally, Canandaigua National Bank & Trust Co. lifted its stake in shares of Colgate-Palmolive by 3.4% during the 4th quarter. Canandaigua National Bank & Trust Co. now owns 12,534 shares of the company’s stock worth $1,139,000 after buying an additional 412 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded up $0.08 during trading on Wednesday, hitting $87.47. The stock had a trading volume of 597,933 shares, compared to its average volume of 3,490,026. The stock’s 50 day moving average is $93.03 and its two-hundred day moving average is $98.31. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30. The stock has a market cap of $71.46 billion, a price-to-earnings ratio of 25.06, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.29%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analysts Set New Price Targets

A number of research firms recently commented on CL. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Wednesday, January 1st. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the company from $105.00 to $101.00 in a report on Monday, October 28th. TD Cowen decreased their price target on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday. Finally, JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $104.16.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.